Paloma Partners Management CO Fennec Pharmaceuticals Inc. Transaction History

Paloma Partners Management CO

  • $3.08 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$4.89 - $8.1 $107,707 - $178,410
-22,026 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$4.25 - $6.49 $88,425 - $135,030
-20,806 Reduced 48.58%
22,026 $143,000
Q3 2019

Nov 14, 2019
SELL
$3.85 - $4.95 $44,536 - $57,261
-11,568 Reduced 21.26%
42,832 $206,000
Q2 2019

Aug 14, 2019
BUY
$3.3 - $5.09 $179,520 - $276,896
54,400 New
54,400 $218,000

Others Institutions Holding FENC

# of Institutions
64
Shares Held
14.9M
Call Options Held
10K
Put Options Held
83.8K
View Full List

About FENNEC PHARMACEUTICALS INC.

FENC Quotes by TradingView
  • Ticker FENC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,067,300
  • Market Cap $104M
  • Description
  • Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...
More about FENC
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email